Cargando…

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer

BACKGROUND: The low level of circulating tumor DNA (ctDNA) in the blood is a well-known challenge for the application of liquid biopsies in early-stage non-small cell lung cancer (NSCLC) management. Studies of metastatic NSCLC indicate that ctDNA levels are associated with tumor metabolic activity a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334612/ https://www.ncbi.nlm.nih.gov/pubmed/37434111 http://dx.doi.org/10.1186/s12885-023-11147-z

Ejemplares similares

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment
por: Ottestad, Anine Larsen, et al.
Publicado: (2022)

Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
por: Halvorsen, Tarje Onsøien, et al.
Publicado: (2020)

Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
por: Graabak, Gustav, et al.
Publicado: (2021)

The undifferentiated carcinoma that became a melanoma: Re-biopsy of a cancer of an unknown primary site: a case report
por: Røe, Oluf Dimitri, et al.
Publicado: (2017)

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions
por: Tøndell, Anders, et al.
Publicado: (2021)

Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC
por: Stokke, Kristin, et al.
Publicado: (2022)

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
por: Palmieri, Maria, et al.
Publicado: (2022)

Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
por: Nilssen, Yngvar, et al.
Publicado: (2023)

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer
por: Tøndell, Anders, et al.
Publicado: (2019)

Identification of exercise‐regulated genes in mice exposed to cigarette smoke
por: Aakerøy, Lars, et al.
Publicado: (2022)

Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
por: Georgi, Thomas W, et al.
Publicado: (2022)

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
por: Horndalsveen, Henrik, et al.
Publicado: (2022)

Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients
por: Grønberg, Bjørn H., et al.
Publicado: (2019)

Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies
por: Sha, Wei, et al.
Publicado: (2013)

Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
por: Jiang, Lin, et al.
Publicado: (2021)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Physiological uptake in FDG PET simulating disease
por: Ahmad Sarji, S
Publicado: (2006)

Riedel’s Thyroiditis with Intense FDG Uptake Demonstrated on FDG PET/CT
por: Mansberg, Robert, et al.
Publicado: (2015)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer
por: Bang, Ji-In, et al.
Publicado: (2018)

An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

Calibrated image-derived input functions for the determination of the metabolic uptake rate of glucose with [(18)F]-FDG PET
por: Christensen, Anders N., et al.
Publicado: (2014)

The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
por: van den Hoff, Jörg, et al.
Publicado: (2013)

Extra-renal malignant rhabdoid tumor of head and neck region: Characteristics of tracer uptake on FDG PET/CT in tumor with rare histology
por: Puranik, Ameya D., et al.
Publicado: (2014)

Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
por: Park, Soeun, et al.
Publicado: (2021)

Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT
por: Shangguan, Chengfang, et al.
Publicado: (2018)

Benign Intrapulmonary Schwannoma With High Uptake on Fluorodeoxyglucose-18 (FDG-18 PET) Presenting as a Pancoast Tumor
por: Chauhan, Sukhjinder, et al.
Publicado: (2023)

Tumor immunity is related to (18)F‐FDG uptake in thymic epithelial tumor
por: Imai, Hisao, et al.
Publicado: (2021)

Benign Colonic (18)F-FDG Uptake on Whole-Body FDG-PET Scan
por: Jang, Byung Ik
Publicado: (2012)

Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT
por: Minamimoto, Ryogo
Publicado: (2021)

A Semi-Automated Technique Determining the Liver Standardized Uptake Value Reference for Tumor Delineation in FDG PET-CT
por: Hirata, Kenji, et al.
Publicado: (2014)

FDG Uptake in PET by Bladder Hernia Simulating Inguinal Metastasis
por: Park, Sung Hee, et al.
Publicado: (2007)

Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET
por: Lindholm, Henry, et al.
Publicado: (2014)

Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2016)

A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate
por: Liu, Yiyan
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r2t46i9hjgjb4ucercbp05qdsg